Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A parametric estimation procedure for relapse time distributions.

L Ahlström1, M Olsson, O Nerman

  • 1Astra Hässle AB, Mölndal.

Lifetime Data Analysis
|July 17, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rapid, sensitive, and specific, low-resource molecular detection of Hendra virus.

One health (Amsterdam, Netherlands)·2023
Same author

Short-term prediction of secondary progression in a sliding window: A test of a predicting algorithm in a validation cohort.

Multiple sclerosis journal - experimental, translational and clinical·2022
Same author

Individual telomere dynamics and their links to life history in a viviparous lizard.

Proceedings. Biological sciences·2021
Same author

Transcriptomes from German shepherd dogs reveal differences in immune activity between atopic dermatitis affected and control skin.

Immunogenetics·2020
Same author

Temperature and telomeres: thermal treatment influences telomere dynamics through a complex interplay of cellular processes in a cold-climate skink.

Oecologia·2019
Same author

The cost of childhood atopic dermatitis in a multi-ethnic Asian population: a cost-of-illness study.

The British journal of dermatology·2019
Same journal

Shared frailty sieve estimation for dependent left truncated and interval censored data.

Lifetime data analysis·2026
Same journal

Functional win-fractions regression models for composite outcomes.

Lifetime data analysis·2026
Same journal

Variable selection in causal semiparametric transformation models with all-or-nothing treatment compliance.

Lifetime data analysis·2026
Same journal

Correction to: A uniformisation-driven algorithm for inference-related estimation of a phase-type ageing model.

Lifetime data analysis·2026
Same journal

Unobserved heterogeneity in threshold regression based on the hitting times of a reflected Brownian motion for recurrent hypoglycemia.

Lifetime data analysis·2026
Same journal

Variable selection with broken adaptive ridge regression for interval-censored competing risks data.

Lifetime data analysis·2026
See all related articles

This study introduces a flexible statistical model for analyzing disease relapse times in clinical trials. The new model, using a partially observable Markov process, accurately captures complex relapse patterns and aids in disease progression understanding.

Area of Science:

  • Biostatistics
  • Clinical Trial Methodology
  • Disease Progression Modeling

Background:

  • Recurrent diseases require accurate relapse time analysis in clinical trials.
  • Current methods may not fully capture the complexities of relapse detection, which can occur at scheduled visits or spontaneous patient reporting.
  • Interval-censored data and symptom-based observations present unique analytical challenges.

Purpose of the Study:

  • To develop a flexible statistical model for analyzing time to relapse in recurrent diseases.
  • To model the joint distribution of time to relapse (X) and time to symptoms (Y) using a partially observable Markov process.
  • To introduce an EM-algorithm for estimating model parameters and evaluate its performance.

Main Methods:

  • Utilizing a partially observable Markov process to model disease progression.

Related Experiment Videos

  • Developing a bivariate phase-type distribution for the joint distribution of relapse time (X) and symptom time (Y).
  • Implementing an Expectation-Maximization (EM) algorithm for parameter estimation.

    • Main Results:

    • The proposed bivariate phase-type distribution model offers flexibility in capturing relapse dynamics.
    • The EM-algorithm provides an effective method for estimating the complex distributions involved.
    • Simulated data analysis demonstrates the model's ability to handle interval-censored and symptom-based relapse data.

    Conclusions:

    • The partially observable Markov process provides a robust framework for modeling disease relapse.
    • The developed EM-algorithm is a viable tool for estimating parameters in this complex model.
    • This approach enhances the statistical analysis of relapse data in clinical trials for recurrent diseases.